# FDA CRL - Revance Therapeutics, Inc. - Unknown Date

Source: https://www.globalkeysolutions.net/records/crl/revance-therapeutics-inc/04992544-f520-4579-9861-784ea9ce1560

> FDA CRL for Revance Therapeutics, Inc. on Unknown Date. Product: BLA. Access full analysis and detailed observations.

---

## Details

- Record Type: CRL
- Company Name: Revance Therapeutics, Inc.
- Product Type: BLA
- Office Name: Office of Immunology and Inflammation

## Related Documents

- [EIR - 2021-07-02](https://www.globalkeysolutions.net/records/eir/revance-therapeutics-inc/1510d06c-9272-4e0c-a5da-eeffa081a9f1)
- [483 - 2025-02-27](https://www.globalkeysolutions.net/records/483/revance-therapeutics-inc/1e4e8ce1-6bdf-4c1a-9d3f-7df594b9a26a)

## Related Officers

- [Michelle R. Frazier, PhD](https://www.globalkeysolutions.net/people/michelle-r-frazier-phd/50ff46a2-9f6b-4202-b5ec-434a464d5ccb)

Company: https://www.globalkeysolutions.net/companies/revance-therapeutics-inc/33277fcf-5886-406e-8332-bc85057ba4bc

Office: https://www.globalkeysolutions.net/offices/office-of-immunology-and-inflammation/fe7fade6-8e5c-4326-b46e-5e2952c95798
